About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials in Chicago | 112 Studies

Clinical Trials Multiple SclerosisChicago

Multiple Sclerosis Clinical Trials in Chicago

Find 112 clinical trials for multiple sclerosis near Chicago, Illinois. Connect with research centers in your area.

All Multiple Sclerosis trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 112 trials

Active not recruitingA Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple SclerosisThis study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sclerosis (PMS).NCT03523858·Laguna Hills, California and 119 others

Multiple Sclerosis Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedSafety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple SclerosisThe purpose of this study is to determine if natalizumab in combination with AVONEX is safe and effective in delaying progression of individuals diagnosed with relapsing remitting…NCT00030966·Birmingham, Alabama and 87 others

Active not recruitingEfficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple SclerosisThe purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the disability progression and the…NCT06141486·Homewood, Alabama and 310 others

TerminatedNivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune DiseaseThe purpose of this study is to explore the safety, tolerability and activity of Nivolumab, a PD-1 inhibitor, in cohorts of patients with autoimmune disease.NCT03656627·Chicago, Illinois and 8 others

CompletedBEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New DoseThe BEYOND Follow-Up study will give patients who participated in the preceding BEYOND study the opportunity to continue treatment with the 500µg dose of interferon beta (IFNB) 1b…NCT00459667·Birmingham, Alabama and 183 others

CompletedEnvironmental and Genetic Risk Factors for Pediatric Multiple SclerosisThe purpose of this study is to better understand multiple sclerosis (MS) in children and adolescents, to learn if it differs from adult MS and to investigate if genes or…NCT01396343·Birmingham, Alabama and 16 others

CompletedCLARITY Extension StudyThe purpose of this extension trial was to further evaluate the safety and tolerability of oral cladribine in subjects who have previously completed treatment within Trial 25643…NCT00641537·Boulder, Colorado and 115 others

CompletedA Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple SclerosisThis is a phase II, multicenter, randomized, parallel-group, partially blinded, placebo and Avonex (interferon beta-1a) controlled dose finding study to evaluate the efficacy as…NCT00676715·Phoenix, Arizona and 83 others

CompletedBEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) PatientsThe purpose of this study is to determine * whether treatment with Betaferon / Betaseron (interferon beta-1b) 500 micrograms safe, tolerable and more efficacious than treatment…NCT00099502·Birmingham, Alabama and 198 others

CompletedEfficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple SclerosisThis study assessed the safety, tolerability and efficacy of two doses of oral fingolimod compared to placebo on efficacy parameters in patients with relapsing-remitting multiple…NCT00355134·Birmingham, Alabama and 111 others

Active not recruitingComparison Between ABP 692 and Ocrevus® (Ocrelizumab)The Main objectives of the study are to demonstrate pharmacokinetic (PK) similarity between ABP 692 and ocrelizumab (US), as well as between ABP 692 and ocrelizumab (EU).NCT06700343·Mobile, Alabama and 108 others

CompletedAn Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a RelapseThis is a Phase 1, multi-center, double-blind, randomized, placebo-controlled, dose-escalation study in subjects with relapsing Multiple Sclerosis (MS).NCT02398461·Long Beach, California and 11 others

Active not recruitingA Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple SclerosisThis is a Phase IIIb, single-arm, multicenter, OLE study.NCT05269004·Phoenix, Arizona and 235 others

Active not recruitingEfficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)NCT05147220·Phoenix, Arizona and 199 others

CompletedTelephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial.The purpose of this study is to investigate the clinical status of patients who participated in the original pivotal Betaseron study at 20 years after randomized treatment…NCT01031459·Birmingham, Alabama and 9 others

CompletedComparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study TwoThe purpose of this study was to establish the efficacy and safety of two different doses of alemtuzumab (Lemtrada™) as a treatment for relapsing-remitting multiple sclerosis…NCT00548405·Cullman, Alabama and 190 others

RecruitingStudy to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of UblituximabThe primary purpose of this phase 3b study is to assess the efficacy of a modified regimen of ublituximab in participants with relapsing multiple sclerosis (RMS) as measured by T1…NCT05877963·Birmingham, Alabama and 50 others

CompletedTeleconference Fatigue Management for People With Multiple SclerosisApproximately 60% of individuals with multiple sclerosis (MS) describe fatigue as their most disabling symptom.NCT00591721·Chicago, Illinois

RecruitingRE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesThe purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with anxiety symptoms in…NCT07002034·Birmingham, Alabama and 31 others

TerminatedAn Efficacy, Safety and Tolerability Study of Glatiramer Acetate (GA) 20 mg/0.5 ml New Formulation Administered Daily by Subcutaneous (SC) Injection in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)This study will investigate the efficacy, safety and tolerability of a new formulation of glatiramer acetate administered at 20 mg/0.5 ml daily versus placebo in patients with…NCT01578785·Cullman, Alabama and 168 others

PreviousPage 3 of 6Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia